Now Hiring - Healthcare Cornea Regional Business Manager in Chicago, IL

Here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve the eyesight of people worldwide. Because we’re a rapidly growing company with a dynamic, fast-paced culture, employees here are empowered with more diverse and enriching challenges than might not be possible at a larger company.

Company: Glaukos Industry: Medical Technology and Pharmaceutical Level: Full time Location: Chicago, IL Compensation: Base Salary Range: $125,000 - $125,000 OVERVIEW Position Summary The Corneal Regional Business Manager responsibilities include developing key growth sales strategies, business development tactics and action plans. Successful execution of these strategies is required to achieve the financial targets. The Corneal Regional Business Manager duties will include hitting annual equipment & procedural targets, building relationships and understanding customer trends driving results. RESPONSIBILITIES Communication Effectively communicate the business value proposition and financial feasibility for capital equipment sales process through proposals/presentation at physician, executive, administrator level. Cohesively work, communicate with the Glaukos RBM peers and other Glaukos departments. Marketing Interact with Marketing Director/Optometric outreach, administrators and develop CXL marketing strategy, deploy resources and drive OD education. Teamwork Collaborate, partner & lead local sales representatives, field reimbursement, marketing, field service and clinical support to ensure commercial success. Motivate Engage, educate, and motivate staff from technicians to billing department on clinical workflow and support procedures. Analysis Identify OD and MD referral opportunities around CXL centers and influence referral patterns. REQUIREMENTS Procedure Proven ability to articulate the distinct value of products, procedures and services against other competitive and non-competitive products. Travel Ability to travel 2-3 nights per week and manage multi-state geography. Sales Proven sales executive experience, meeting or exceeding targets. Experience Minimum 3 years Ophthalmic Medical Device, Surgical Device or pharmaceutical sales experience. 5-10 years proven track record in sales performance in the medical device industry. Previous experience as a sales executive, sales manager or sales & marketing manager. Marketing Concentration in Business or Marketing preferred. Degree Bachelor’s degree or equivalent experience. Procedure Proven ability to articulate the distinct value of products, procedures and services against other competitive and non-competitive products. Travel Ability to travel 2-3 nights per week and manage multi-state geography. Sales Proven sales executive experience, meeting or exceeding targets. Experience Minimum 3 years Ophthalmic Medical Device, Surgical Device or pharmaceutical sales experience. 5-10 years proven track record in sales performance in the medical device industry. Previous experience as a sales executive, sales manager or sales & marketing manager. Marketing Concentration in Business or Marketing preferred. Degree Bachelor’s degree or equivalent experience. ‹ › ABOUT US Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device—the iStent®—in the United States, followed by our next-generation iStent inject® device in September 2018 and iStent inject® W in September 2020. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies for glaucoma, corneal health, and retinal diseases.